spacer
home > pmps > summer 2002 > liposomes as drug delivery systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Liposomes as Drug Delivery Systems

The usefulness of liposomes in pharmacy and medicine as carriers of active substances has been postulated since the early 1960s, when the phenomenon of encapsulation of some chemical compounds in lipide microspheres was recognised. However, it was only in the past few years that the objective proof of therapeutic efficacy when using this method of drug delivery was realised and the first launches of liposomal drug dosage forms took place.

Basic Information on Liposomes

Liposomes are microscopic or submicroscopic structures of 10nm to 20mm in diameter. They are made up of one or many concentrically arranged lipid bilayers constituting an envelope. The basic matter of liposomes are amphiphilic compounds having clearly separated hydrophilic and hydrophobic centres. Hydrophilic components of lipides of bilayer are directed towards aqueous phases (external and internal), whereas hydrophobic components of both lipide layers are directed towards one another, forming the internal layer of a membrane.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Piotr Slifirski, Head of the Pharmaceutical Department
at the Pharmaceutical Research Institute in Poland Dr Piotr Slifirski is a Head of Pharmaceutical Department at the Pharmaceutical Research Institute in Warsaw, Poland.
Piotr studied Pharmacy at the Academy of Medicine in Warsaw. He holds a PhD in Pharmacy from the Academy of Medicine in Wroclaw, Poland, and specialises in drugs technology.

spacer
Dr Piotr Slifirski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Irelandís premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement